Intravenous administration of monoclonal antibody to the platelet GP IIb/IIIa receptor to treat abrupt closure during coronary angioplasty.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  American Journal of Cardiology

• Publication date

  1992-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9149(92)91242-VPMID 1585878
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Spontaneous alterations in coronary blood flow velocity before and after coronary angioplasty in patients with severe angina.

  1991cited by this paper
• Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris.

  1990cited by this paper
• Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.

  1990cited by this paper
• Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty.

  1990cited by this paper
• Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb/IIIa antibody.

  1990cited by this paper
• Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.

  1988cited by this paper

• Drug Information Rounds

  2015cites this paper
• CHAPTER 62 – αIIbβ3 (GPIIb-IIIa) Antagonists

  2007cites this paper
• Kawai Pathogenesis of Acute Myocardial Infarction 1035 Regulatory System of Bioactive Substances in the Vessel Wall in Evolving Myocardial Infarction

  2005cites this paper
• Deteriorates After Acute Myocardial Infarction

  2005cites this paper
• Drugs for the prevention of coronary thrombosis: From an animal model to clinical trials

  2004cites this paper
• Glycoprotein IIb/IIIa Antagonists

  2003cites this paper
• Platelets and Cardiovascular Disease

  2002cites this paper
• Interventionelle Kardiologie. Pathologie und klinisch-pathologische Korrelationen der Ballondilatation und alternativer Methoden. Restenosen

  2000cites this paper
• Abciximab: The First Platelet Glycoprotein IIb/IIIa Receptor Antagonist

  1999cites this paper
• Current Antiplatelet Therapy

  1999cites this paper
• Diminishing impact of in-lab complications.

  1997cites this paper
• Concept and Clinical Application of Platelet Glycoprotein IIb/IIIa Inhibition with Abciximab (c7E3 Fab; ReoPro) for the Prevention of Acute Ischemic Syndromes

  1997cites this paper
• Pitfalls and Practical Approach to the Use of Imaging Techniques in Developing Clinical Strategies

  1997cites this paper
• James Thornton Willerson, MD: A Conversation With the Editor1

  1997cites this paper
• Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.

  1997cites this paper
• Drug Information Rounds

  1997cites this paper
• James Thornton Willerson, MD: a conversation with the editor. Interview by William Clifford Roberts.

  1997cites this paper
• Abrupt vessel closure: changing importance, management, and consequences.

  1997cites this paper
• Adjunctive intracoronary thrombolysis in complicated coronary angioplasty.

  1997cites this paper
• 14. AND PRACTICAL APPROACH TO THE

  1997cites this paper
• Cyclic flow variations after angioplasty: a rare phenomenon predictive of immediate complications. DEBATE Investigator's Group.

  1996cites this paper
• Anti-platelet monoclonal antibodies for the prevention of arterial thrombosis: experience with ReoPro, a monoclonal antibody directed against the platelet GPIIb/IIIa receptor.

  1995cites this paper
• Section Review—Cardiovascular & Renal: Integrins and Cardiovascular Disease

  1995cites this paper
• Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy.

  1995cites this paper
• Kinetics of platelets in dogs with thrombocytopenia induced by antiglycoprotein IIb/IIIa receptor monoclonal antibody.

  1995cites this paper
• Peptide Mimetics as Adhesion Molecule Antagonists

  1994cites this paper
• Liposome-bound prostaglandin E1 often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteries.

  1994cites this paper
• Collagen-targeted antibodies inhibit platelet-dependent thrombosis in vivo.

  1994cites this paper
• Pathogenesis of acute myocardial infarction. Novel regulatory systems of bioactive substances in the vessel wall.

  1994cites this paper
• Antithrombotic Effects of DMP 728, a Platelet GPIIb/IIIa Receptor Antagonist, in a Canine Model of Arterial Thrombosis

  1994cites this paper
• Mechanisms of restenosis.

  1994cites this paper
• The pharmacology of the integrins

  1994cites this paper
• Alterations in coronary blood flow velocity during intracoronary thrombolysis and rescue coronary angioplasty for acute myocardial infarction.

  1994cites this paper
• Continuous coronary flow velocity monitoring during coronary interventions: velocity trend patterns associated with adverse events.

  1994cites this paper
• Therapeutic Potential of Integrin Antagonists

  1994cites this paper
• Abolition of Cyclic Flow Variations in Stenosed, Endothelium‐Injured Coronary Arteries in Nonhuman Primates With a Peptide Fragment (VCL) Derived From Human Plasma von Willebrand Factor–Glycoprotein Ib Binding Domain

  1994cites this paper
• Thrombus and unstable angina.

  1993cites this paper
• The Effects of Two Synthetic Glycoprotein II b/III a Antagonists, Ro 43-8857 and L-700,462, on Platelet Aggregation and Bleeding in Guinea-Pigs and Dogs: Evidence that Ro 43-8857 Is Orally Active

  1993cites this paper
• Coronary artery flow monitoring following coronary interventions.

  1993cites this paper
• Thrombus and unstable angina

  1993cites this paper
• Application of intracoronary flow velocity for detection and management of ostial saphenous vein graft lesions.

  1993cites this paper
• A 49-year-old woman with hypertension who deteriorates after acute myocardial infarction.

  1993cites this paper